L98-22137-36174
4 vaccinations
1 coded response
36 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 970 / OR
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Dose 1 — Moderna
-
2021-01-19
Registered in v-safe
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-02-01
- 2021-02-08
-
2021-02-15
Dose 2 — Moderna
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-03-03
- 2021-03-10
- 2021-03-15
- 2021-03-23
- 2021-03-29
- 2021-05-19
-
2021-11-11
Dose 3 — Pfizer-BioNTech
-
2021-11-11
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
-
2021-11-12
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-11-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-17
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
-
2021-12-23
Survey response — day 42, dose 3MedDRA: Aphasia, Headache, Paraesthesia, Thinking abnormal, Visual impairment — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Visual disturbances, aphasia, paresthesias, and difficulty processing thoughts that preceded headache.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-23
Report sent to call center — day 42, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2021-12-27
- 2022-01-12
-
2022-01-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-10
- 2022-05-12
-
2022-09-16
Dose 4 — ModernaCo-administered: Flu
- 2022-10-10
- 2022-10-21
- 2022-10-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Moderna | |
| 2 | 2021-02-15 | Moderna | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Moderna | Flu |
Call center
1 call center case
1 successful
Free text
Release 10 — day 42, dose 3
Symptoms: Visual disturbances, aphasia, paresthesias, and difficulty processing thoughts that preceded headache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Aphasia | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Thinking abnormal | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release